Follow-up Guidelines for Completely Resected Gastroenteropan
New guidelines from an international expert panel suggest less-frequent follow-up in the short term, but longer follow-up periods overall, for completely resected gastroenteropancreatic neuroendocrine tumors (NETs).

The Commonwealth Neuroendocrine Tumour Collaboration convened an international multidisciplinary expert panel, in collaboration with the North American Neuroendocrine Tumor Society, to create patient-centered follow-up recommendations. The guidelines have been published in JAMA Oncology.

Some of the key recommendations are:-
• For pancreatic NETs, the research team recommends that follow-up consultation with CT or MRI imaging should be performed every year for the first three years and then every year or two for a total of 10 years.

• Patients with any positive lymph nodes or a Ki-67 index greater than 5% should be followed-up more frequently and for at least 10 years.

• However, patients with grade 1, node-negative tumors smaller than 2 cm are among those considered at sufficiently low clinical risk to warrant no follow-up.

The North American Neuroendocrine Tumor Society (NANETS) is a society of over 400 multidisciplinary medical professionals committed to the support of the medical community in treating neuroendocrine tumor (NET) patients, as well as furthering NET science and education in North America.

Note: This list is a brief compilation of some of the key recommendations included in the guidelines and is not exhaustive and does not constitute medical advice. Kindly refer to the original publication here: A detailed presentation of the guidelines can be read here:
Dr. R●j D●v and 1 others like this3 shares